Hand Osteoarthritis: Clinical Trials

7 trials for Hand Osteoarthritis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 3 recruiting, 1 unknown. 7 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 37Completed 3, Recruiting 3, Unknown 1
Phase 22Completed 1, Unknown 1

Follow Hand Osteoarthritis: new trials by email Literature Review of Hand Osteoarthritis trials Research Report on Hand Osteoarthritis

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Multiprofen-CC to Reduce Pain in Hand Arthritis
Multiprofen-CC™ plus standard treatment, Placebo plus standard treatment - Hand Osteoarthritis
Phase 3RecruitingSt. Joseph's Healthcare Hamilton422026-03-092026-05-04
The Efficacy and Safety of Intramuscular Methylprednisolone in Patients With Hand OsteoArthritis
120mg methylprednisolone acetate, 40mg methylprednisolone acetate, Placebo - Hand Osteoarthritis
Phase 3RecruitingSint Maartenskliniek2122025-10-282026-01-28
Metformin Treatment of Patients with Hand Osteoarthritis
Metformin, Placebo - Hand Osteoarthritis
Phase 3RecruitingMarius Henriksen1502024-06-032025-02-27
Efficacy and Safety of Iguratimod in Patients With Hand Osteoarthritis (ESIGO)
Iguratimod, placebo - Hand Osteoarthritis, Inflammatory Arthritis
Phase 2 / Phase 3UnknownPeking University People's Hospital1502022-03-012022-02-08
Effect of the Interleukin-6 Receptor Antagonist Tocilizumab in Patients With Hand Osteoarthritis
tocilizumab, saline solution - Hand Osteoarthritis
Phase 3CompletedAssistance Publique - Hôpitaux de Paris1042015-11-202019-07-30
Efficacy of Shinabro in Hand Osteoarthritis
Shinbaro, Placebo - Hand Osteoarthritis
Phase 2 / Phase 3CompletedSeoul National University Hospital2202013-09-012015-12-17
Efficacy Study of an Anti-Tumor Necrosis Factor (TNF) Alpha Agent in Patients With Hand Osteoarthritis
Adalimumab (Humira®), Placebo - Hand Osteoarthritis
Phase 3CompletedAssistance Publique - Hôpitaux de Paris842008-01-012012-07-26

Narrower conditions

Osteoarthritis (4)  ·  Arthritis (2)

Broader conditions

Joint Diseases (5)  ·  Musculoskeletal Diseases (5)  ·  Rheumatic Diseases (4)  ·  Arthritis (3)

Interventions

Saline Solution (2)  ·  Adalimumab (1)  ·  Metformin (1)  ·  Methylprednisolone (1)  ·  Methylprednisolone Acetate (1)  ·  Sodium Chloride (1)  ·  iguratimod (1)  ·  shinbaro (1)  ·  tocilizumab (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (2)  ·  Marius Henriksen (1)  ·  Peking University People's Hospital (1)  ·  Seoul National University Hospital (1)  ·  Sint Maartenskliniek (1)  ·  St. Joseph's Healthcare Hamilton (1)

Countries

France (2)  ·  Canada (1)  ·  Denmark (1)  ·  Netherlands (1)  ·  South Korea (1)

Top investigators

Carolyn Levis, MD, MSc, FRCS(C) (1)  ·  Eun Bong Lee, MD PhD (1)  ·  Jin Kyun Park, MD (1)  ·  Kichul Shin, MD PhD (1)  ·  Richette Pascal, MD, PhD (1)  ·  Xavier Chevalier, PU-PH (1)  ·  Yun Jong Lee, MD PhD (1)

Results publications

PMID 24817417, PMID 27449412, PMID 40139705

NIH funding

2023 (1)